illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Aim Vaccine
Company logo

Aim Vaccine | Sustainability Performance

https://en.aimbio.com/
Linkedin

Concentrates on the research, development, and production of vaccines targeting infectious diseases.

2011

China

1,001 - 5,000 employees

Pharmaceuticals

$100M - 500M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#9116
Overall
#355
in China
#211
in Pharmaceuticals

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and exclusions
Financial Data
Business performanceCapital & innovation

View similiar companies


Company logo
BioKangtai

China, Hospital & Health Care, Biotechnology


Company logo
Shandong Buchang Pharmaceuticals

China, Hospital & Health Care, Pharmaceuticals


Company logo
INT Medical Instruments

China, Hospital & Health Care, Medical Device

Market cap

12.3B $, 2026▼179.4% YoY

Revenue

163.5M $, 2026

R&D intensity

16.36% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

12.3B $, 2026▼179.4% YoY

Revenue

163.5M $, FY2026▼NaN% YoY

EBITDA

0.0 $, FY2026▼9.1% YoY

Operating margin

-18% Industry: -24▼3.6% YoY

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-19.5M 2024▼235.9% YoY

Capex

33.4M 2024▼26.5% YoY

Debt/equity ratio

0.6 Industry: 0▼NaN% YoY

R&D intensity

16.4%FY2025

R&D as % of revenue

R&D as % of revenue
Industry benchmark

Powered by illuminem

Return on invested capital

-15.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

19%
Independent Directors

3 out of 16 incl. management

Powered by illuminem

Overall score

0

Environment

0

Social

0

Governance

0

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email